Genkyotex Company

Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety and efficacy over existing antioxidants therapy, giving them a significant competitive advantage. Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.

Technology: Geroscience
Industry: Regenerative medicine
Headquarters: Geneva, Geneve, Switzerland
Founded Date: 2006
Employees Number: 11-50
Funding Status: IPO

Visit Website
Register and Claim Ownership